Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPennon Regulatory News (PNN)

Share Price Information for Pennon (PNN)

Share Price is delayed by 15 minutes
Get Live Data
482.40    -16.40 (-3.29%)
Bid:
482.00
Ask:
482.60
Spread: 0.60 (0.124%)
Market Cap: £2.28b
PNN Live PriceLast checked at - London Stock Exchange

Intraday Pennon Share Chart

South West Water Accepts Final Determination

14 Feb 2020 07:00

RNS Number : 9838C
Pennon Group PLC
14 February 2020
 

PENNON GROUP PLC

14 February 2020

SOUTH WEST WATER ACCEPTS FINAL DETERMINATION

As part of the Price Review 2019 (PR19) process, South West Water's Final Determination for the period 2020-2025 (K7) was published by Ofwat on 16 December 2019. After careful consideration, Pennon Group is announcing today that South West Water will not be applying for this to be referred to the Competition and Markets Authority (CMA).

Importantly for customers, by 2025 South West Water bills will be lower than they are today and lower than they were 15 years earlier.

South West Water's Final Determination also includes;

·; a totex allowance of c.£2bn (wholesale and residential retail) - consistent with South West Water's Draft Determination in April 2019

·; a suite of outcome delivery incentives reflecting the priorities of our customers

·; an innovative customer sharing mechanism - WaterShare+ which offers customers a tangible stake and a greater say in the business.

An investor document summarising key metrics from Ofwat's Final Determination has been published on the Pennon website and can be accessed by the following link: https://www.pennon-group.co.uk/investor-information

Following the decision to accept South West Water's Final Determination, the outcome will be taken into account as part of the ongoing review of the strategic focus, growth options and capital allocation policy for the Pennon Group.

Pennon's current dividend policy expires in 2020, and it is Pennon's intention to announce a new dividend policy by the full year results announcement scheduled for 4 June 2020.

For further information, please contact:

 

Pennon

 

Susan Davy

Chief Financial Officer

01392 443 168

Sarah Heald

Director of Corporate Affairs & Investor Relations

Jennifer Cooke

Investor Relations Officer

 

Finsbury

 

James Murgatroyd

0207 251 3801

Harry Worthington

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCUORRRRKUUAUR
Date   Source Headline
10th Jun 20267:00 amRNSFull Year Results 2025/26
1st Jun 20267:00 amRNSTotal Voting Rights
29th May 20262:06 pmRNSHolding(s) in Company
20th May 20261:48 pmRNSDirector/PDMR Shareholding
14th May 202612:03 pmRNSDirector/PDMR Shareholding
6th May 20262:12 pmRNSAdmission to Trading
1st May 20264:31 pmRNSHolding(s) in Company
1st May 20267:00 amRNSTotal Voting Rights
30th Apr 20263:11 pmRNSHolding(s) in Company
27th Apr 20264:34 pmRNSHolding(s) in Company
24th Apr 20263:29 pmRNSHolding(s) in Company
22nd Apr 20264:30 pmRNSHolding(s) in Company
21st Apr 20261:17 pmRNSDirector/PDMR Shareholding
20th Apr 20264:09 pmRNSHolding(s) in Company
14th Apr 20264:24 pmRNSRescheduled Full-Year Results Date
1st Apr 20267:00 amRNSTotal Voting Rights
20th Mar 20262:06 pmRNSDirector/PDMR Shareholding
10th Mar 20267:00 amRNSTrading Statement
2nd Mar 20267:00 amRNSTotal Voting Rights
23rd Feb 202612:58 pmRNSDirector/PDMR Shareholding
10th Feb 20267:00 amRNSConfirmation of Chief Executive Officer Start Date
5th Feb 202610:58 amRNSHolding(s) in Company
2nd Feb 20267:01 amRNSTotal Voting Rights
2nd Feb 20267:00 amRNSBlock listing Interim Review
23rd Jan 20263:21 pmRNSDirector/PDMR Shareholding
2nd Jan 20267:00 amRNSTotal Voting Rights
2nd Jan 20267:00 amRNSTotal Voting Rights
23rd Dec 20253:29 pmRNSDirector/PDMR Shareholding
23rd Dec 20253:29 pmRNSDirector/PDMR Shareholding
11th Dec 20251:16 pmRNSConfirmed Financial Calendar
9th Dec 20254:01 pmRNSDirector/PDMR Shareholding
9th Dec 20257:00 amRNSPennon Group CEO Transition Arrangements
1st Dec 20253:42 pmRNSEMTN: Publication of Supplementary Prospectus
1st Dec 20257:00 amRNSTotal Voting Rights
27th Nov 20257:00 amRNSHalf Year Results 2025/26
21st Nov 20254:24 pmRNSDirector/PDMR Shareholding
3rd Nov 20257:00 amRNSTotal Voting Rights
22nd Oct 20251:26 pmRNSDirector/PDMR Shareholding
7th Oct 20257:00 amRNSPennon appoints new Non-Executive Director
3rd Oct 20252:19 pmRNSDirector/PDMR Shareholding
2nd Oct 20257:00 amRNSPennon Group appoints Keith Haslett as new CEO
1st Oct 20257:00 amRNSTotal Voting Rights
26th Sep 20257:00 amRNSTrading Statement
23rd Sep 20254:16 pmRNSDirector/PDMR Shareholding
11th Sep 202512:09 pmRNSEMTN Programme: Publication of Final Terms
1st Sep 20257:00 amRNSTotal Voting Rights
28th Aug 20252:44 pmRNSDirector/PDMR Shareholding
22nd Aug 20259:41 amRNSEMTN Programme: Publication of Base Prospectus
20th Aug 20254:15 pmRNSDirector/PDMR Shareholding
1st Aug 20257:01 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.